Transgene S.A.

TRGNF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$19-$17-$16-$6
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$0$0
Change in WC$1$14-$3-$1
Other Non-Cash-$1-$3$1-$11
Operating Cash Flow-$18-$5-$18-$17
Investing Activities
PP&E Inv.-$0-$1-$2-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$36
Other Inv. Act.-$0-$1$1$18
Investing Cash Flow-$1-$2-$1$17
Financing Activities
Debt Repay.$20$29$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$21$19$25
Financing Cash Flow$20$8$19$12
Forex Effect-$1$0$0$0
Net Chg. in Cash$17$1-$0$12
Supplemental Information
Beg. Cash$0$15$16$4
End Cash$17$17$15$16
Free Cash Flow-$18-$6-$20-$18